Aston Particle Technologies
Private Company
Total funding raised: $2M
Overview
Aston Particle Technologies is a private, pre-revenue platform company spun out from Aston University in 2016 (founded 2018) to commercialize its proprietary isothermal dry particle coating (iDPC) technology. Its core innovation is a dry, solvent-free, and directly scalable process for coating small molecules and biologics onto carrier particles, addressing key formulation challenges in drug delivery. APT operates as a service and technology provider, supporting partners from pre-clinical development through early-phase manufacturing with its in-house expertise and pilot-scale capabilities. The company is backed by grant funding and investors, positioning itself at the intersection of advanced manufacturing and formulation science.
Technology Platform
Patented isothermal dry particle coating (iDPC) technology. A low-shear, solvent-free, one-step process for coating nano/micro particles onto larger carrier particles without heat or mechanical mixing, enabling precise formulations for inhalational, biological, and oral solid dose medicines.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
APT competes within the niche of advanced particle engineering against other dry coating technology providers and specialized CDMOs. Its primary differentiation is the combination of isothermal (no heat), solvent-free, and directly scalable processing in a single platform, which is particularly compelling for heat- and shear-sensitive biologics. Larger, full-service CDMOs represent both potential competitors and future acquirers or partners.